Handelsblatt
Handelsblatt front page of the first issue | |
| Type | Daily newspaper |
|---|---|
| Format | Compact |
| Owner | Handelsblatt Media Group |
| Editor | Sebastian Matthes |
| Founded | 16 May 1946 |
Political alignment | Economic liberalism |
| Language | German |
| Headquarters | Düsseldorf |
| Circulation | 127,546 (Print, 2018) 42,000 (Digital, 2018) |
| ISSN | 0017-7296 |
| Website | www.handelsblatt.com |

The Handelsblatt (literally "commerce paper" in English) is a German-language business newspaper published in Düsseldorf by Handelsblatt Media Group, formerly known as Verlagsgruppe Handelsblatt.[1]
History and profile
[edit]Handelsblatt was established in 1946 by journalist Herbert Gross, but after some months Friedrich Vogel (1902–1976) became publisher.[2][3] In 1969, Georg von Holtzbrinck became partner of Friedrich Vogel. Since 2021, its editor-in-chief is Sebastian Matthes.[4] Its publisher, Handelsblatt Media Group, also publishes the weekly business magazine Wirtschaftswoche[5] of which the editor-in-chief is Beat Balzli.[6] Handelsblatt's headquarters are in Düsseldorf.[7]
In 2009, Dieter von Holtzbrinck bought Der Tagesspiegel, Handelsblatt and Wirtschaftswoche from the Georg von Holtzbrinck Publishing Group.[citation needed]
Handelsblatt had a circulation of 127,546 daily copies in 2018.[8]
Handelsblatt Today
[edit]An English-language digital edition was launched in 2014, called Handelsblatt Global Edition, which aimed to reach an international audience interested in German business and finance news. It was published five days a week from its editorial office in Berlin with editor-in-chief, Kevin O'Brien at the helm.[9] In 2017, under a new editor-in-chief, Andreas Kluth, the publication avoided the direct translation of German-language articles and instead worked through differences between German and Anglophone journalistic traditions to add details that English readers were accustomed to.[10] The site was renamed Handelsblatt Today in 2018, but, unable to create a business model and reach a substantial audience to generate revenue, Kluth announced that publication would cease on 27 February 2019.[11]
Anti-Vaccine controversy
[edit]On the 25th of January 2021, Handelsblatt published an unsourced story falsely claiming that the Oxford-Astrazeneca COVID-19 vaccine was only 8% effective in over 65's. Astrazeneca and the University of Oxford issued statements denying these claims.[12][13] This story was refuted by the German Health Ministry which clarified that 8% actually referred to the number of people in the study between 56 and 69 years old.[14][15][16] Markus Lehmkuhl, the Karlsruhe Institute of Technology's Professor for Science Communication, stated that Handelsblatt "turned the matter into a 'he says, she says' story to absolve itself of responsibility for spreading stupid stuff."[17]
Editors-in-chief
[edit]- Herbert Gross (1946 for some months)
- Friedrich Vogel
- Hans Mundorf
- Thomas Knipp (2002–2004) and Bernd Ziesemer (2002–2010)
- Gabor Steingart (2010–2013)
- Hans-Jürgen Jakobs (2013–2016)
- Sven Afhüppe (2016–2020)
- Sebastian Matthes (since 2020)
References
[edit]- ^ "Verlagsgruppe Handelsblatt übernimmt Konferenzveranstalter und benennt sich um" [Handelsblatt publishing group takes over conference organizer and renames itself]. horizont.net (in German).
- ^ Carsten Croonenbroeck; Roman Matkovskyy (July 2013). "Is the Market Held by Institutional Investors? The Disposition Effect Revisited" (Discussion paper. No: 338). European University Viadrina Frankfurt. Retrieved 3 February 2015.
- ^ Robert G. Picard, ed. (2002). Media Firms: Structures, Operations, and Performance. Mahwah, NJ: Lawrence Erlbaum Associates. p. 61. Archived from the original on 26 December 2014.
- ^ "Sebastian Matthes wird neuer Handelsblatt-Chefredakteur" [Sebastian Matthes will be the new editor-in-chief of Handelsblatt]. wuv.de (in German). 25 November 2020.
- ^ "Handelsblatt and WiWo continue to lead the German market". Advance Media. Archived from the original on 3 February 2015. Retrieved 3 February 2015.
- ^ "Beat Balzli wird Chefredakteur der 'Wirtschaftswoche'" [Beat Balzli will become editor-in-chief of 'Wirtschaftswoche']. new-business.de (in German).
- ^ "German Online Newspapers and Magazines". Almania Information Center. Archived from the original on 2 January 2015. Retrieved 28 March 2015.
- ^ "Homepage" (in German). IVW. Archived from the original on 17 December 2014. Retrieved 3 August 2014.
- ^ ""Handelsblatt" bringt englischsprachige Ausgabe an den Start" [Handelsblatt launches English-language edition]. Focus Online (in German). Hubert Burda Media. Retrieved 7 July 2015.
- ^ Kluth, Andreas (27 February 2019). "Farewell: What I learned about journalism while running Handelsblatt Today". Handelsblatt Today. Handelsblatt GmbH. Retrieved 5 December 2019.
{{cite web}}: CS1 maint: deprecated archival service (link) - ^ Kluth, Andreas (1 November 2018). "Handelsblatt Today: About us". Handelsblatt Today. Handelsblatt GmbH. Retrieved 5 December 2019.
{{cite web}}: CS1 maint: deprecated archival service (link) - ^ "AstraZeneca says reports of 8% coronavirus vaccine efficacy in seniors are 'incorrect'". Global News. Retrieved 26 January 2021.
- ^ Boytchev, Hristio (12 February 2021). "Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?". BMJ. 372: n414. doi:10.1136/bmj.n414. ISSN 1756-1833. PMID 33579678.
- ^ "German paper's excruciating Oxford vaccine muddle". www.spectator.co.uk. The Spectator. Retrieved 26 January 2021.
- ^ "Pandemie-Bekämpfung: Rückschlag bei Corona-Impfstoff: Astra-Zeneca-Vakzin wirkt bei Senioren offenbar kaum" [Pandemic control: Setback for coronavirus vaccine: AstraZeneca vaccine appears to have little effect on seniors]. www.handelsblatt.com (in German). Retrieved 26 January 2021.
- ^ Barnes, Joe (26 January 2021). "German Health Ministry DENIES bombshell vaccine claims – says Berlin paper messed up stats". Express.co.uk. Retrieved 26 January 2021.
- ^ Boytchev, Hristio (2021). "Why did a German newspaper insist the Oxford Astra Zeneca vaccine was inefficacious for older people—without evidence?". BMJ. 372: n414. doi:10.1136/bmj.n414. PMID 33579678. S2CID 231884653.
